S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Price, News & Analysis

$3.80
-0.12 (-3.06%)
(As of 03/28/2024 ET)
Today's Range
$3.80
$3.93
50-Day Range
$2.61
$4.91
52-Week Range
$1.79
$5.38
Volume
51,211 shs
Average Volume
161,478 shs
Market Capitalization
$62.28 million
P/E Ratio
126.71
Dividend Yield
N/A
Price Target
$7.50

Sensus Healthcare MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
97.4% Upside
$7.50 Price Target
Short Interest
Healthy
0.51% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.71mentions of Sensus Healthcare in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.58 out of 5 stars

Medical Sector

506th out of 938 stocks

Surgical & Medical Instruments Industry

57th out of 94 stocks

SRTS stock logo

About Sensus Healthcare Stock (NASDAQ:SRTS)

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SRTS Stock Price History

SRTS Stock News Headlines

Sensus Healthcare Inc.
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
A Market With a Hangover
3 Stocks to Buy That Are Up 100% or More in 2024
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Q4 2023 Sensus Healthcare Inc Earnings Call
Earnings Preview For Sensus Healthcare
See More Headlines
Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/29/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SRTS
Employees
42
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.50
High Stock Price Target
$8.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+97.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$490,000.00
Pretax Margin
2.67%

Debt

Sales & Book Value

Annual Sales
$24.41 million
Cash Flow
$0.05 per share
Book Value
$2.98 per share

Miscellaneous

Free Float
14,574,000
Market Cap
$62.28 million
Optionable
Optionable
Beta
0.92
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Joseph C. SardanoMr. Joseph C. Sardano (Age 71)
    Co-Founder, Chairman & CEO
    Comp: $754.43k
  • Mr. Michael J. Sardano (Age 35)
    President, General Counsel, Corporate Secretary & Director
    Comp: $404.74k
  • Mr. Javier Rampolla (Age 51)
    Chief Financial Officer
    Comp: $439.14k
  • Ms. Magdalena Martinez (Age 34)
    Chief Operating Officer
  • Mr. Emiliano Sosa (Age 46)
    Chief Technology Officer
  • Sean Delaney
    Vice President of Regulatory Affairs & Compliance
  • Ms. Stephanie Tipton
    Vice President of Marketing
  • Dr. Mark S. Nestor
    Medical Director & Member of Medical Advisory Board
  • Dr. Clay Jefferies Cockerell (Age 67)
    Clinical Director & Member of Medical Advisory Board

SRTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings
or view top-rated stocks.

What is Sensus Healthcare's stock price target for 2024?

1 brokerages have issued 1-year price objectives for Sensus Healthcare's stock. Their SRTS share price targets range from $7.00 to $8.00. On average, they expect the company's stock price to reach $7.50 in the next year. This suggests a possible upside of 97.4% from the stock's current price.
View analysts price targets for SRTS
or view top-rated stocks among Wall Street analysts.

How have SRTS shares performed in 2024?

Sensus Healthcare's stock was trading at $2.36 at the beginning of 2024. Since then, SRTS stock has increased by 61.0% and is now trading at $3.80.
View the best growth stocks for 2024 here
.

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 65,800 shares, an increase of 166.4% from the February 29th total of 24,700 shares. Based on an average daily trading volume, of 165,400 shares, the short-interest ratio is presently 0.4 days. Currently, 0.5% of the shares of the company are short sold.
View Sensus Healthcare's Short Interest
.

When is Sensus Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our SRTS earnings forecast
.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) issued its quarterly earnings results on Thursday, February, 8th. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.14. The company earned $12.57 million during the quarter, compared to analyst estimates of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a trailing twelve-month return on equity of 1.04%.

What guidance has Sensus Healthcare issued on next quarter's earnings?

Sensus Healthcare updated its fourth quarter 2023 earnings guidance on Tuesday, January, 23rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $12.0 million-, compared to the consensus revenue estimate of $7.5 million.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

Sensus Healthcare (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Who are Sensus Healthcare's major shareholders?

Sensus Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (1.08%), Perritt Capital Management Inc. (0.80%), Sachetta LLC (0.64%), Dimensional Fund Advisors LP (0.42%), Northern Trust Corp (0.38%) and Creekmur Asset Management LLC (0.21%). Insiders that own company stock include Javier Rampolla, John Heinrich, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall.
View institutional ownership trends
.

How do I buy shares of Sensus Healthcare?

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SRTS) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners